Is nalidixic acid resistance linked to clinical virulence in Salmonella enterica serovar Typhi infections?
Kadhiravan
Tamilarasu
T
Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Wig
Naveet
N
Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
Renuka
K
K
Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Kapil
Arti
A
Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Kabra
Sushil K
SK
Department of Paediatrics, All India Institute of Medical Sciences, New Delhi, India.
Misra
Anoop
A
Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000494:pharmacology / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D008297:Male; D009268:Nalidixic Acid / Q000494:pharmacology / Q000627:therapeutic use*; D012485:Salmonella typhi / Q000187:drug effects / Q000472:pathogenicity*; D016019:Survival Analysis; D014435:Typhoid Fever / Q000188:drug therapy* / Q000401:mortality; D014774:Virulence
D000890:Anti-Infective Agents; D009268:Nalidixic Acid